1·The study also confirmed that adding fenofibrate to simvastatin did not result in any excess risk of myopathy (muscle problems), venous thrombosis or pancreatitis.
这项研究同样证实将非诺贝特加入辛伐他汀不会引起任何肌病(肌肉病变)，静脉血栓或胰脏炎等多余危害。
2·The risk of myopathy is also increased when simvastatin, especially at the higher doses, is used with certain drugs (see Simvastatin Dose Limitations below).
当辛伐他汀（特别是大剂量）与某些药物联合服用时，也会增加肌病的风险。
3·Objective: To understand the adverse effects of simvastatin and promote rational medication.
目的了解辛伐他汀的副作用，提倡合理用药。
4·Simvastatin is sold as a single-ingredient generic medication and as the brand-name Zocor.
作为单一成分出售的辛伐他汀是非专利药，商品名为舒降之。
5·Conclusions Simvastatin, after 16 weeks of treatment, can be lower vascular obstruction, increase blood flow, and thus improve brain blood supply.
结论辛伐他汀治疗16周可以通过降低血管阻力增加血流量改善脑血管供血状态。